MAGEA3 and cancer: In order to consider this issue, we provide below a non-exhaustive review of several systems: the mouse class I pepMHC-specific TCR (2C), a mouse class II pepMHC-specific TCR (3.L2), and human TCRs against the cancer antigens MART-1, NY-ESO, MAGE-A3, and WT1.